Tag: biologic manufacturing

29 Dec
Lot-to-Lot Variability in Biologics and Biosimilars: What It Means for Patients and Providers
Simon loxton

Lot-to-Lot Variability in Biologics and Biosimilars: What It Means for Patients and Providers

Lot-to-lot variability is a natural part of biologic and biosimilar manufacturing. Unlike generics, these drugs contain millions of slightly different protein versions in each batch. Learn how this variation is managed, why it doesn't affect safety, and what it means for patients and labs.

View More 12

recent posts

Exercise-Induced Bronchoconstriction: How to Prevent It and Use Your Inhaler Right
Exercise-Induced Bronchoconstriction: How to Prevent It and Use Your Inhaler Right

Published on: 1 Feb

Manufacturer Copay Assistance Cards: How to Use Them
Manufacturer Copay Assistance Cards: How to Use Them

Published on: 3 Feb

How to Monitor Kidney Function for Safe Senior Dosing
How to Monitor Kidney Function for Safe Senior Dosing

Published on: 19 Feb

Gabapentin vs Pregabalin: Which Is Best for Neuropathic Pain?
Gabapentin vs Pregabalin: Which Is Best for Neuropathic Pain?

Published on: 4 Feb

SGLT2 Inhibitors and Fournier’s Gangrene: Early Warning Signs and What to Do
SGLT2 Inhibitors and Fournier’s Gangrene: Early Warning Signs and What to Do

Published on: 11 Feb

categories

archives

tags